Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Once-Trusted Investment Advisor Burrill Faces Criminal Fraud Charges

Executive Summary

A federal grand jury indicted Steven Burrill and an associate on charges of fraud and tax evasion regarding investment funds run by the San Francisco-based life science advisor, who settled a related SEC claim in 2016. If convicted, he could spend decades in prison and pay millions in fines.

You may also be interested in...



SEC Bars Biotech's Burrill, Settles VC Fund Theft Charges

He may not be into buying $2m Wu-Tang Clan hip-hop albums, like another biotech executive that's recently found himself in hot water, but Steven Burrill apparently likes his vacations to St. Barts and Paris and spending cash, which allegedly wasn't his own, on private jets and Tiffany jewelry and other gifts for his wife – and his girlfriend, according to the Securities and Exchange Commission (SEC).

Employee Lawsuit Withdrawn, But Burrill Faces New Investor Claims

A lawsuit filed by an employee who oversaw venture capital funds run by Steven Burrill has been dismissed, but a separate lawsuit filed against Burrill, a prominent San Francisco-based advisor to life science companies, has been amended with new accusations against the fund's auditor, PricewaterhouseCoopers (PwC).

Trusted biotech investor, advisor Burrill accused of fraud

Trusted life science investor, lender and advisor Steven Burrill's reputation is on the line in a lawsuit filed by a former employee who claims that Mr Burrill and his companies took more than $19m from a venture capital fund that they managed.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC099537

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel